2 Clinical Trial Sites approved to Participate in Clinical Trial for Dry AMD Read more…
Michael T. Heffernan, RPh appointed to the board of directors Read more…
Gregory D. Perry and Zohar Loshitzer have been appointed to the Board of Directors, effective today.
ACT or OTC BB: ACTC has appointed Dr Robert S. Langer to the Board of Directors, Read more…
Moorfields Eye Hospital in London is Site for P1/2 Trial to Treat Stargardt’s Macular Dystrophy Read more…
ACTC.OB had a net loss of $1.9M or ($0.00) per share. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.